Silicon Laboratories (SLAB) Cash & Equivalents (2009 - 2026)

Silicon Laboratories has reported Cash & Equivalents for 18 years, with the latest figure at $362.2 million in Q3 2026.

• On a quarterly basis, Cash & Equivalents rose 15.18% year-over-year to $362.2 million in Q3 2026; TTM through Jul 2026 was $362.2 million, a 15.18% increase from a year earlier, with the FY2026 full-year figure at $364.2 million, up 29.34% from the prior year.
• Cash & Equivalents was $362.2 million for Q3 2026 at Silicon Laboratories, down from $383.1 million in the prior quarter.
• The five-year high for Cash & Equivalents was $1.1 billion in Q1 2022, with the low at $159.9 million in Q3 2023.
• Average Cash & Equivalents over 5 years is $409.2 million, with a median of $341.4 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents surged 430.1% in 2022, then slumped 73.27% in 2024.
• Over 5 years, Cash & Equivalents stood at $499.9 million in 2022, then plunged by 54.49% to $227.5 million in 2023, then gained by 23.78% to $281.6 million in 2024, then increased by 21.23% to $341.4 million in 2025, then grew by 6.09% to $362.2 million in 2026.
• The last three Cash & Equivalents figures came in at $362.2 million (Q3 2026), $383.1 million (Q2 2026), and $364.2 million (Q1 2026), per Business Quant data.